In this video, Saakshi Khattri, MBBS, MD, discussed questions and concerns around the impact COVID-19 has on patients with psoriatic disease, including drug interactions.
“Right now, we don’t know exactly how having psoriasis or psoriatic arthritis or being on treatments meaningfully alters a patient’s risk or whether it heralds a worse outcome from COVID-19,” Khattri, assistant professor of dermatology, rheumatology and internal medicine at Icahn School of Medicine at Mount Sinai, explained.
She also touched on adapting to telehealth visits and recommendations if a patient is diagnosed with, or has symptoms of, SARS-COV-2 infection.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.